Double-blind, randomized, multicentre, and active comparator controlled investigation of the effect of Pioglitazone, Metformin, and the combination of both on cardiovascular risk in patients with type 2 diabetes receiving stable basal insulin therapy: the PIOCOMB study

BACKGROUND: We analyzed specific effects of an add-on therapy with pioglitazone compared to metformin and their combination in patients with basal insulin treatment on biomarkers of CV risk. METHODS: In this double-blind, randomized, multicentre, active comparator controlled trial, 121 patients with...

Descripción completa

Detalles Bibliográficos
Autores principales: Hanefeld, Markolf, Pfützner, Andreas, Forst, Thomas, Kleine, Iris, Fuchs, Winfried
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3160877/
https://www.ncbi.nlm.nih.gov/pubmed/21756323
http://dx.doi.org/10.1186/1475-2840-10-65

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3160877/
https://www.ncbi.nlm.nih.gov/pubmed/21756323
http://dx.doi.org/10.1186/1475-2840-10-65

Ejemplares similares